Top

Published in:

01-01-2022 | Original Article

Work-related factors related to forgetting to take oral diabetes medication during the working day among Japanese male employees with diabetes

Authors: Nao Sonoda, Soichiro Watanabe, Yuko Ohno, Chieko Hatamochi, Yoshie Sugimoto, Maiko Shikama, Meng Li, Akiko Morimoto

Published in: Diabetology International | Issue 1/2022

Abstract

Aim

This study aimed to explore the work-related factors related to forgetting to take oral diabetes medication during the working day among Japanese employees with diabetes.

Methods

This worksite-based study was designed to clarify the important work-related factors for preventing the aggravation of diabetes among working-age people and support for coexisting diabetes treatment and work (Ryoritsu Shien). This cross-sectional survey was conducted in 2018. The participants were full-time employees with type 2 diabetes aged over 40 years who took oral diabetes medication during the working day. The participants were classified into forgetting and non-forgetting groups. Their characteristics and work-related factors were evaluated using a self-administered questionnaire and specific health checkup data.

Results

Of the 93 employees with diabetes, 22 (23.7%) were classified into the forgetting group. After adjusting for confounding factors, irregular meal times during the working day was positively associated with forgetting to take oral diabetes medication during the working day [multivariable-adjusted odds ratio (OR), 7.08; 95% confidence interval (CI): 1.38–36.32, irregular vs. regular]. Skipping meals during the working day was positively associated with forgetting to take oral diabetes medication during the working day (multivariable-adjusted OR 3.55, 95% CI 1.14–11.09 presence vs. absence).

Conclusions

Our findings suggest that irregular meal times and skipping meals during the working day are important factors related to forgetting to take oral diabetes medication during the working day among Japanese male employees with diabetes.

International Diabetes Federation. IDF Diabetes Atlas 9th edition 2019. https://www.diabetesatlas.org/upload/resources/material/20200302_133351_IDFATLAS9e-final-web.pdf. Accessed 1 Apr 2021.

Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836–41.CrossRef

Fukuda H, Mizobe M. Impact of nonadherence on complication risks and healthcare costs in patients newly-diagnosed with diabetes. Diabetes Res Clin Pract. 2017;123:55–62.CrossRef

Lin LK, Sun Y, Heng BH, Chew DEK, Chong PN. Medication adherence and glycemic control among newly diagnosed diabetes patients. BMJ Open Diabetes Res Care. 2017. https://doi.org/10.1136/bmjdrc-2017-000429.CrossRefPubMedPubMedCentral

Ando S, Ito H, Tanaka M, Tsugami E, Araki R, Matsumoto S, et al. The current status and background factors of unused drugs in patients with type 2 diabetes: a cross-sectional study using a questionnaire survey. J Japan Diab Soc. 2018;61:375–81 (in Japanese).

Japan organization of Occupational Health and Safety. Support manual for coexistence of treatment and work for workers with diabetes 2017. https://www.johas.go.jp/Portals/0/data0/kinrosyashien/pdf/bwt-manual-dm01.pdf. Accessed 1 Apr 2021 (in Japanese).

Ministry of Health, Labour and Welfare. Guidelines for supporting coexistence of treatment and work in workplace 2020. https://www.mhlw.go.jp/content/11200000/000614130.pdf. Accessed 1 Apr 2021 (in Japanese).

Kirkman MS, Rowan-Martin MT, Levin R, Fonseca VA, Schmittdiel JA, Herman WH, et al. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database. Diabetes Care. 2015;38:604–9.PubMedPubMedCentral

Marzec LN, Maddox TM. Medication adherence in patients with diabetes and dyslipidemia: associated factors and strategies for improvement. Curr Cardiol Rep. 2013;15:418.CrossRef

10.

Sonoda N, Watanabe S, Ohno Y, Godai K, Hatamochi C, Sugimoto Y, et al. Work-related, personal, and diabetes-related factors relevant to dropout from outpatient diabetes treatment visits among Japanese mafle employees with diabetes. Diabetol Int. 2020;11:261–8.CrossRef

11.

Morimoto A, Watanabe S, Ohno Y, Godai K, Hatamochi C, Sugimoto Y, et al. Associations among work-related stress and mental fatigue, and regular exercise in Japanese employees with or without diabetes. Diabetol Int. 2020;11:105–13.CrossRef

12.

Kawakami N, Fujigaki Y. Reliability and validity of the Japanese version of job content questionnaire: replication and extension in computer company employees. Ind Health. 1996;34:295–306.CrossRef

13.

Kawakami N, Kobayashi F, Araki S, Haratani T, Furui H. Assessment of job stress dimensions based on the Job demands-control model of employees of telecommunication and electric power companies in Japan: reliability and validity of the Japanese version of job content questionnaire. Int J Behav Med. 1995;2:358–75.CrossRef

14.

Chuang LL, Lin KC, Hsu AL, Wu CY, Chang KC, Li YC, et al. Reliability and validity of a vertical numerical rating scale supplemented with a faces rating scale in measuring fatigue after stroke. Health Qual Life Outcomes. 2015;13:91.CrossRef

15.

Soejima Y, Munemoto T, Masuda A, Uwatoko Y, Miyata M, Tei C. Effects of waon therapy on chronic fatigue syndrome: a pilot study. Intern Med. 2015;54:333–8.CrossRef

16.

Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, et al. The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer. 1999;88:1186–96.CrossRef

17.

Tanaka K, Obara T, Kobayashi M, Shinki T, Shibamiya T, Nishimura M, et al. Medication compliance and intentional discontinuation of taking medication among outpatients. J Drug Interact Res. 2009;32:21–7 (in Japanese).

18.

Osanai Y, Katsura S, Sato H, Kimura R, Kodama H, Takasugi K, et al. Evaluation of the factors influencing medicine-taking behavior for the patients taking oral medication. Jpn J Soc Hosp Pharm. 2015;34:72–80 (in Japanese).

19.

Tanaka R, Tsuji M, Kusuhara K, Kawamoto T, Japan Environment and Children’s Study Group. Association between time-related work factors and dietary behaviors: results from the Japan Environment and Children’s Study (JECS). Environ Health Prev Med. 2018. https://doi.org/10.1186/s12199-018-0753-9.CrossRefPubMedPubMedCentral

20.

Ministry of Health, Labor and Welfare. An overview of the national health and nutrition survey 2016 Results. https://www.mhlw.go.jp/bunya/kenkou/eiyou/dl/h28-houkoku-03.pdf. Accessed 4 Apr 2021 (in Japanese).

21.

Mallion JM, Schmitt D. Patient compliance in the treatment of arterial hypertension. J Hypertens. 2001;19(12):2281–3.CrossRef

22.

Kanda K, Okada Y, Morita E, Sugimoto H, Tanaka Y. Problems related to the treatment of working diabetic patient. J Japan Diab Soc. 2005;48:309–15 (in Japanese).

Title: Work-related factors related to forgetting to take oral diabetes medication during the working day among Japanese male employees with diabetes
Authors: Nao Sonoda
Soichiro Watanabe
Yuko Ohno
Chieko Hatamochi
Yoshie Sugimoto
Maiko Shikama
Meng Li
Akiko Morimoto
Publication date: 01-01-2022
Publisher: Springer Singapore
Published in: Diabetology International / Issue 1/2022
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI: https://doi.org/10.1007/s13340-021-00532-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Aim

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

Correction to: Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity

Japanese Type 1 Diabetes Database Study (TIDE-J): rationale and study design

Formation of large abscess tumor including gallstone in ileum during therapy for hyperosmolar hyperglycemic syndrome: a case report

Efficacy of dulaglutide after switching from incretin-related drugs in patients with type 2 diabetes and inadequate glycemic control

Correction to: Non-autoimmune acute-onset type 1 diabetes mellitus newly developed in an elderly patient presenting elevation of serum pancreatic exocrine enzymes

Patient characteristics associated with improvement in glycemic control following addition of an oral antidiabetic drug to DPP-4 inhibitor monotherapy in Japanese patients with type 2 diabetes mellitus (JDDM 60)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials